Investor Relations Education & Training Portal Logins CONTACT PRODUCTS & SERVICES THERAPEUTIC AREAS CUSTOMER SUPPORT ABOUT US ABOUT US Who We Are Core Values Locations Corporate Social Responsibility Humane Care Initiative Eureka Science Community Investor Relations News & Events Careers Investor Relations Investor Relations Investor Relations Home Corporate Governance Annual Meeting 2013 Stock Information News Releases Financial Information SEC Filings Presentations Analyst Information Calendar Shareholder Services Webcast Q3 2013 Charles River Laboratories International, Inc. Earnings Conference Call (Live) 10/30/13 at 8:00 a.m. ET Corporate Profile Accelerating Drug Development. Exactly. Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com. News Releases More » DATE TITLE 09/26/13 Charles River Laboratories Schedules Third-Quarter 2013 Earnings Release and Conference Call 09/26/13 Charles River Laboratories Appoints John Crowley as Corporate Senior Vice President, Corporate Controller and Chief Accounting Officer 09/09/13 Charles River Laboratories to Present at Morgan Stanley Global Healthcare Conference 07/31/13 Charles River Laboratories Announces Second-Quarter 2013 Results from Continuing Operations Upcoming Events More » DATE TITLE 10/30/13 8:00 a.m. ET Q3 2013 Charles River Laboratories International, Inc. Earnings Conference Call Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Minimum 20 minutes delayed Stock Quote CRL (common) Price $47.81 Change (%) + 0.21 (0.44%) Volume 218,430 Exchange NYSE (US Dollar) Data as of 10/21/13 4:02 p.m. ET REFRESH QUOTE Featured Report 2012 Annual Report (Interactive) Investor Hotline 877-567-6CRL (6275) Toolkit Print Page Email Page RSS Feeds Email Alerts IR Contacts Financial Tear Sheet Careers Press Resources Investor Relations Connect with Us: RSS Twitter Facebook LinkedIn YouTube © 2021 Charles River Laboratories International, Inc. Legal Terms & Conditions Privacy Policy Safe Harbor Privacy Policy Products & Services Research Models & Services Discovery Research Services Preclinical Services Biopharmaceutical Services Endotoxin Detection & Microbial Identification Avian Vaccine Services Chemicals, Agro & Vet Therapeutic Areas Bone & Skeletal Disease Cardiovascular Central Nervous System Metabolic Disease Inflammation Oncology Ophthalmology Respiratory Disease Contact Us Locations Initiate a Project News & Events What's New at Charles River Education & Training